Pierre Leblond

18PUBLICATIONS
166CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 24, 2026
Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial.

|Feb 27, 2026
From Diagnosis Delay to Targeted Therapy: A Retrospective Study of Pediatric DLGNT with a Comprehensive Literature Review.

Riccardo De Carli, Viviana Minichini, Laetitia Lebrun

|Aug 06, 2025
Metastatic Low-Grade Glioma Successfully Treated in a Pediatric Patient With BRAF A598_T599insI Mutation.

Pierluigi Calò, Safiatou Diallo, Laetitia Lebrun

|Jun 27, 2025
Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 cases.

Aurelien Maureille, Enora Vauleon, David Meyronet

|Apr 02, 2025
The state of targeted therapeutic pharmacological approaches in pediatric neurosurgery: report from the European Society for Pediatric Neurosurgery (ESPN) Consensus Conference 2024.

P Frassanito, U W Thomale, M Obersnel

|Jan 10, 2025
Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology.

Clémence Deligne, Arthur Tourbez, Flavie Bénard

Pageof 3

Frequent Collaborators

3 joint publications

Natacha Entz-Werle

3 joint publications

David Meyronet

3 joint publications

Marc Barritault

3 joint publications

Federico Di Rocco